Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T47DKBLUC | Unknown | Unknown | Bosutinib | Src | nRTK | 0.0000853 | uM | 12608.17 | 0.9465 | 0.9006 | 1.0776 | |
| T47DKBLUC | Unknown | Unknown | Bosutinib | Src | nRTK | 0.000427 | uM | 12608.17 | 0.9526 | 0.9120 | 1.0776 | |
| T47DKBLUC | Unknown | Unknown | Bosutinib | Src | nRTK | 0.267 | uM | 12608.17 | 0.9685 | 0.9415 | 1.0776 | |
| T47DKBLUC | Unknown | Unknown | Bosutinib | Src | nRTK | 0.0107 | uM | 12608.17 | 0.9741 | 0.9519 | 1.0776 | |
| T47DKBLUC | Unknown | Unknown | Bosutinib | Src | nRTK | 0.0533 | uM | 12608.17 | 0.9640 | 0.9331 | 1.0776 | |
| T47DKBLUC | Unknown | Unknown | Bosutinib | Src | nRTK | 33.3 | uM | 12608.17 | 0.7944 | 0.6154 | 1.0776 | |
| HMT-3522 T4-2 | Unknown | Unknown | Carboplatin | DNA cross-linker | DNA cross-linker | 10.8 | uM | 10147.021 | 0.9396 | 0.9438 | 2.1856 |